If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com).  The website is updated approximately twice a month.

PDP Press Releases/ statements

IAVI 

 • 1 Jun: IAVI to advance vaccine candidate for Bundibugyo virus, receives funding from CEPI

• 3 Jun: IAVI joins international partnership to accelerate promising TB vaccine candidate in late-stage development

• 29 Jun: Optimizing antibodies for antimicrobial resistance

IVCC

 • 25 Jun: World Health Organization report highlights how insecticide-treated net durability could shape malaria control decisions

 • 24 Apr: Kim Johnson MP visits malaria researchers ahead of World Malaria Day

 • 24 Apr: Advancing tools for outdoor mosquito control: IVCC and Swedish University of Agricultural Sciences launch new collaboration

TB Alliance

• 6 Apr: TB Alliance Congratulates Bruce Carter on His Appointment as an Officer of the Order of the British Empire

• 12 Apr: New Report: LIFT-TB Helped Cut Time to Global Uptake of Improved Drug-Resistant TB Treatments from Nearly a Decade to Three Years

• 14 Apr: Closing the Gap Between Impact and Innovation

• 24 Apr: Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments

GARDP 

• Jun 8: DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need

Population Council

 • 4 Feb: Contraline and Population Council Execute Global Exclusive License Agreement for NES/T Male Contraception Gel

PATH

• 23 Jun: PATH's next chapter in digital health innovation

• 20 Apr: Decentralizing molecular diagnostics: Four insights from user evaluations

MMV

• 5 Jun: Coartem® Baby awarded MMV’s Project of the Year 2025

• 8 Jun: DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need

• 17 Jun: MMV and DNDi pool regulatory expertise to accelerate access to lifesaving medicines

• 29 Jun: African manufacturers’ perspectives on the successes, challenges and expected benefits of producing quality-assured antimalarials

DNDi

• 8 Jun: DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need

• 9 Jun: DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)

• 12 Jun: DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness

• 17 Jun: MMV and DNDi pool regulatory expertise to accelerate access to lifesaving medicines

• 29 Jun: Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors 

FIND

•  9 Apr: Dr Ayoade Alakija Appointed to the Accra Reset initiative

IVI

• 8 Jun: IVI partners in ACT-CHIK consortium to advance chikungunya vaccine development and manufacturing in Africa

• 26 Jun: IVI, KDCA, and RIGHT Foundation host 2026 Global Vaccine Forum on advancing equitable access to next-generation vaccines

EVI

• 2 Jun: New study makes economic case for placental malaria vaccine, with first-time mothers standing to benefit most

• 9 Jun: Powering Europe's pandemic response: EVI and partners to offer vaccine R&D expertise and resources to applicant developers through ISIDORe II

MDGH

• 30 Jan: MDGH starts its Phase 2 clinical trial of dovramilast in people with leprosy type 2 reaction

PDP Funder News/Announcements

• 3 Jun: UK launches expert network to boost Ebola response and global crisis readiness. UK Government

• 15 Jun: Novo Nordisk Foundation and Global Health EDCTP3 launch funding partnership to advance global health research. EDCTP3

• 17 Jun: GHIT Fund kick-started emergency product development support for Ebola disease outbreak caused by Bundibugyo virus. GHIT

• 26 May: Announcing the Strep A Vaccine Fund. Coefficient Giving

Funder Announcement Archives

     •     2014 PDP Funder Announcements

     •     2013 PDP Funder Announcements

New PDP Publications

•  29 Jun: Advancing global health innovation through Europe-Africa collaboration. Numerous PDPs

Other Reports/ Publications

• 10 Mar: Tools to fight AMR exist, but industry-wide action is needed to tilt the battle against superbugs. Access to Medicines Foundation

• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies

Related Press Releases/ Announcements/Articles

• 1 Jun: CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates. CEPI

• 1 Jun: Congo Ebola Outbreak Now Third-Largest on Record as Suspected Cases Pass 1,000. Health Policy Watch

• 1 Jun: Debugging: Google requests permission to release 32m mosquitoes in California and Florida. The Guardian

• 1 Jun: The race is on to develop Bundibugyo Ebola vaccines. Devex

• 1 Jun: Offline: The dishonest politics of global health, Richard Horton. The Lancet

• 1 Jun: Charting Ebola Responses: How 2026 Stacks Up After Aid Cuts. Think Global Health

• 1 Jun: Africa CDC: Ebola Emergency Underscores The Access to Countermeasures in the Negotiations On Pathogen Access & Benefit Sharing. Geneva Health Files

• 1 Jun: As Ebola Spreads, Scientists Race to Find Vaccines and Treatments. The New York Times

• 2 Jun: Only the Right Tests Can Stop This Ebola Outbreak. Congo Has Hardly Any. The New York Times

• 2 Jun: Devex CheckUp: Who is funding what in the Ebola response?. Devex

• 2 Jun: Merck weighs use of COVID antiviral Lagevrio as Ebola outbreak worsens. Fierce Pharma

• 2 Jun: Phase 1 clinical trial set to begin on first leishmaniasis vaccine. Ohio State News

• 2 Jun: Can Africa pay for its own outbreaks? Ebola offers an early test. Devex

• 2 Jun: Tuberculosis test may improve diagnosis. NIH

• 2 Jun: The Chagas disease time bomb in Latin America’s cities. The Telegraph

• 2 Jun: Collaboration will be key in race for vaccine to control rare Ebola strain. Gavi

• 2 Jun: Scientists identify possible cause of noma, the disease that destroys children’s faces. Gavi

• 2 Jun: Rubio says US is considering naming official to run Ebola response. Reuters

• 2 Jun: Better diagnostics could have limited this Ebola outbreak. Nature

• 2 Jun: Rubio Suggests U.S. Return to Global Vaccine Program in Rebuke of Kennedy. The New York Times

• 3 Jun: This Is Why You Don’t Slash Humanitarian Aid. The New York Times

• 3 Jun: CEPI funds next phase of nanoparticle vaccine platform to support rapid outbreak response. CEPI

• 3 Jun: No data, no direction. Impact Global Health

• 3 Jun: White House may appoint Ebola lead, Rubio tells lawmakers. Devex

• 3 Jun: NIH cuts weakened network primed to respond to outbreaks like Ebola. STAT

• 3 Jun: WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined. Health Policy Watch

• 3 Jun: Malaria is gaining ground—but researchers are developing promising new solutions. Harvard

• 3 Jun: Scientific Breakthroughs and Political Retreat Set the Stage for a Crucial Global Moment in the Fight Against HIV/AIDS. Global Dispatches

• 3 Jun: Implementation determinants of rapid diagnostics tests for fever management in sub-Saharan Africa: a mixed-studies systematic review. Nature

• 4 Jun: Ending HIV requires research in and with South Africa. The Lancet HIV

• 5 Jun: Accelerating vaccine research and development for skin neglected tropical diseases: A case for leishmaniasis, leprosy, and Buruli ulcer. PLOS

• 5 Jun: Durability of the insecticidal activity of next-generation insecticide treated nets distributed for malaria control in Mozambique: Findings from the New Nets Project (2020–2022). PLOS

• 5 Jun: From market failure to epidemic preparedness: the race for a Bundibugyo Ebola vaccine. Gavi

• 5 Jun: What the Ebola outbreak demands from global leaders in 2026. Gavi

5 Jun: The fatal Ebola outbreak in the DRC needs faster, simpler tests. Devex

• 5 Jun: Ghana eyes 2027 launch of first locally produced vaccine with $50 million investment push. Pulse

• 5 Jun: WHO and Africa CDC Launch Joint Ebola Response Plan Amid Serious Local Challenges. Health Policy Watch

• 6 Jun: Responding to Ebola: a test. The Lancet

• 6 May: Non-sputum testing: an incomplete bridge across the tuberculosis diagnostic gap. The Lancet

• 6 May: Throwing basket of diagnostics, drugs, vaccines and mozzie stoppers at malaria has not stopped the disease. Mail & Guardian

• 6 May: Restoring certainty to global health regulation. BMJ

• 6 May: Fourteen days to recovery from kala-azar. Nature

• 6 May: New inhibitor design provides a blueprint for effective malaria treatments. NewsMedical

• 7 Jun: Tanzania's bold experiment against malaria. DW

• 8 Jun: Non-Profit R&D Groups Pool Resources Amid Shrinking Global Budgets. Health Policy Watch

• 8 Jun: FG targets new tools to tackle malaria scourge. The Guardian Nigeria

• 8 Jun: Gavi plans to use US cash for malaria, while meeting Kennedy's conditions. Reuters

• 8 Jun: The Power of Science for Health: Malawi’s Milestones Transforming Lives. WHO

• 8 Jun: As climate shifts, malaria gains ground in southern Africa. MedicalXpress

• 8 Jun: Can We Win the Malaria Arms Race?. Health Policy Watch

• 8 Jun: CEPI awards Public Health Vaccines US$1.9m to accelerate Bundibugyo ebolavirus vaccine. CEPI

• 8 Jun: How CEPI can enhance global vaccine equity and transparency. The Lancet

• 8 Jun: Inclusion of young adolescents in policy development for new tuberculosis vaccines. The Lancet

• 8 Jun: Accelerating chikungunya vaccine development in Africa: Launch of the ACT-CHIK Project. First Word Pharma

• 8 Jun: Inside WHO and Africa CDC’s $518M Ebola response plan. Devex

• 9 Jun: Seth Berkley has seen our pandemic future. Devex

• 9 Jun: New TB vaccines are on the horizon. In Zambia, scientists are already figuring out how best to deploy it. Gavi

• 9 Jun: World’s first AI‑designed vaccine explained. Gavi

• 9 Jun: Muyembe: DRC’s Ebola Response Must Be Anchored Locally. Health Policy Watch

• 9 Jun: Lenacapavir: the HIV Breakthrough Proving Why NIH Funding Matters. Think Global Health

• 9 Jun: Bundibugyo Ebola without vaccines or therapeutics: why public health fundamentals matter more than border closures. Nature

• 9 Jun: To reset global development, invest in global south research and innovation. Devex

• 9 Jun: First-in-human clinical trial shows promising results for new Lassa fever vaccine. University of Maryland

• 9 Jun: CEPI awards Public Health Vaccines US$1.9m to accelerate Bundibugyo ebolavirus vaccine. CEPI

• 10 Jun: The hunt for a new Ebola vaccine: two scientists explain the challenges. The Conversation

• 10 Jun: First-Ever Dual Vaccine for Lassa Virus and Rabies Deemed Safe in Human Trial. Discover Magazine

• 10 Jun: Rwanda: €15m Vaccine Clinical Trial On Mosquito-Borne Viral Disease Launched. All Africa

• 10 Jun: Can global health reform without creating new fragmentation?. Devex

• 10 Jun: Did US aid cuts break precisely the things we need most for the lenacapavir rollout? Spotlight

• 10 Jun: Trump administration has its sights set on destroying international research collaborations. BMJ

• 11 Jun: FG deploys new tools to tackle malaria scourge. The Guardian Nigeria

• 11 Jun: The Gates Foundation’s push for stronger African health product regulators. Devex

• 11 Jun: Reforming the Global Health Architecture: Power Relations, Jockeying for Influence, and the Efforts to Break Free from Status Quo. Geneva Health Files

• 12 Jun: It’s possible to have a collective success’: three Geneva health non-profits bolster ties amid shrinking aid. Geneva Solutions

• 12 Jun: Saving Women From Bleeding to Death After Giving Birth. Health Policy Watch

• 12 Jun: New pan-European network to develop novel diagnostics for infectious diseases. 360Dx

• 12 Jun: Global antimicrobial resistance threats forecast to rise by 2050, King’s College study finds. Innovation News Network

• 12 Jun: US to provide $50 mln more in funding to counter Ebola outbreak. Reuters

• 13 Jun: GSK Opens New Front in Malaria Prevention With First-in-Human Antibody Trial. The Globe & Mail

• 13 Jun: Urgent need for a reliable rapid diagnostic test for the Ebola epidemic caused by Bundibugyo virus in Africa. The Lancet

• 13 May: Centering Women, Children, and Adolescents in Global Health Reform. Think Global Health

• 14 May: Innovation without access is not progress: what the EU's new health initiative must deliver. Unitaid

• 14 May: Scientists map research gaps between West Africa and a lassa fever vaccine. Modern Ghana

• 14 May: Rethinking Global Health Reform After COVID-19: Legitimacy Before Authority. IHP

• 14 May: The global health system must radically change to survive and thrive. The Telegraph

• 14 Jun: Inside the race to develop a new Ebola vaccine. Scientific American

• 14 Jun: Leading Malaria Scientist Warns Tools Alone Will Not End the Disease. Health Policy Watch

• 15 Jun: Advances in the development of malaria vaccines. BMJ

• 15 Jun: US Support for Ebola Response is Unclear Amid Opaque Funds Disbursement and Non-Engagement with WHO. Health Policy Watch

• 15 Jun: WHO issues first ever guidance to advance child-focused dengue treatments. WHO

• 15 Jun: What Will It Take to Get a Bundibugyo Vaccine?. Johns Hopkins

• 16 Jun: Global Fund partners with CIFF to bring new TB tests to 13 countries. Devex

• 16 Jun: What the hantavirus and Ebola outbreaks tell us about pandemic preparedness. Nature

• 17 Jun: Could a hantavirus vaccine be on the horizon?. Gavi

• 17 Jun: EU supports Ebola response with €493 million in vaccines, treatment and health aid. Reuters

• 17 Jun: AI tool could speed antibiotic development. Health Research Matters

• 17 Jun: Beyond bread and beer: Alluring yeast species could yield new mosquito traps to combat malaria. Johns Hopkins University

• 17 Jun: Advocacy groups urge US to share experimental Ebola drug for outbreak trials. Reuters

• 17 Jun: Opinion: Global health reform must bolster innovation. Project Syndicate

• 17 Jun: Medical innovation in LMICs: can India lead the way?. Nature

• 17 Jun: Pharmaceutical industry mobilizes to support response to the Ebola Bundibugyo virus disease outbreak and calls for a system that enables rapid response and sustained R&D investment. Nature

• 18 Jun: Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July. Reuters

• 18 Jun: Ebola response received less than 10% of pledges, Africa CDC says. Reuters

• 18 Jun: US CDC activates $107 million in emergency funding for Ebola response. Reuters

• 18 Jun: Can market shaping improve medicine access across Africa?. Resolve

• 18 Jun: What happens when the world’s best HIV prevention tool meets the planet’s deadliest infectious disease?. Bhekisisa

• 18 Jun: Is Kenya’s lenacapavir rollout missing young women and girls?. Devex

• 18 May: Scientists play catch-up to startling Ebola outbreak. Science

• 18 May: Race begins to trial Ebola drugs amid current outbreak. Nature

• 19 Jun: Rollout of 5,000 near point-of-care TB test systems in 13 countries begins with $50M in funding. 360Dx

• 19 Jun: Africa CDC chief says the continent needs to invest its own funds in Ebola response, vaccine. AP

• 19 Jun: The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years. Wired

• 19 Jun: Instituting solidarity: the role of research institutes in advancing global health equity. Health Research & Policy Systems

• 19 May: Democratizing global health governance: mission impossible?. People’s Dispatch

• 19 May: The Global Fund and Africa CDC Join Forces for Stronger, Self-Reliant Health Systems. The Global Fund

• 19 May: African Health leaders forge unified position on Global Health Reform ahead of WHA79 in Geneva. Tech Review Africa

• 19 May: African Leadership Drives HIV Prevention Access. AVAC

• 19 May: Vaccine experts debate options to combat outbreak of unusual Ebola strain. Science

• 19 May: Behind the Mission to Stop Viral Outbreaks Within 100 Days. Time

• 19 May: Bridging the gap in TB case detection. Nature

• 19 May: Decolonising Neglected Tropical Diseases research in Africa: insights, challenges and promising practices. BMJ

• 19 May: Disease outbreaks such as Ebola and hantavirus are more frequent and deadly as world “moves backwards,” report warns. BMJ

• 19 May: European Union and Singapore Back CEPI’s Plan to Boost Global Defences Against Epidemic and Pandemic Threats. CEPI

• 20 Jun: Rapid tests for Bundibugyo virus in DR Congo. The Lancet

• 20 May: In Mali, one year in, hybrid malaria vaccine programme shows early results. Gavi

• 20 May: Africa CDC and Team Europe Launch Landmark Report Showing Health R&D Could Generate $668 Billion for African Economies. Africa CDC

• 20 May: After a critique from Rubio, WHO defends work on Ebola response. STAT

• 20 May: EU, Singapore pledge nearly $100M for CEPI amid fresh Ebola outbreak. Devex

• 20 May: Vaccine to tackle Ebola outbreak will take six to nine months, says WHO. The Guardian

• 21 May: Ebola responders say aid cuts by Western nations left them ill-equipped for outbreak. Washington Post

• 21 May: Stopping Outbreaks at Source: Pandemic Preparedness Stumbles at Local Level. Health Policy Watch

• 21 May: Ebola responders say aid cuts by Western nations left them ill-equipped for outbreak. The Washington Post

• 21 May: Country Leap into Action: advancing country-led global health architecture reform. Gavi

• 21 May: Are We Reforming Global Health or Washing Our Hands Of It?. Institute for New Economic Thinking

• 21 May: Whose science? A bioethical case for sovereign stewardship in African research and development financing. The Lancet

• 21 May: Gavi statement on the Ebola disease outbreak in Democratic Republic of the Congo and Uganda. Gavi

• 21 May: Collaboration will be key in race for vaccine to control rare Ebola strain. Devex

• 21 May: Gavi statement on scaling innovative financing for the next pandemic. Gavi

• 21 May: UK commits $26.87 million to contain Ebola outbreak in DRC. Reuters

• 21 May: New consensus document on AMR education positions children as agents of change. TWN

• 21 May: Ebola outbreak: the data that show why researchers are so alarmed. Nature

• 21 May: Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost. Health Policy Watch

• 22 Jun: African vaccine manufacturing is advancing, but the path to market has revealed challenges. CHAI

• 22 Jun: Inequities in HIV prevention: strategic access and equity in injectable PrEP distribution. The Lancet

• 22 Jun: The lenacapavir paradox: why a promising prevention tool raises difficult questions about African HIV response priorities. The Lancet

• 22 Jun: Inclusion of young adolescents in policy development for new tuberculosis vaccines. The Lancet

• 22 Jun: Malaria should worry us more than genetically modified mosquitoes. Devex

• 22 Jun: More than 50 organisations call on the EU to ensure that medicines funded by public money are accessible. Salud por Derecho

• 22 May: Bundibugyo, the rare virus causing a deadly new Ebola outbreak, has no vaccine yet. Here’s what we know. Gavi

• 22 May: Ebola Emergency Frames The Pathogen Access Benefit Sharing System As Key For Global Health Security. Geneva Health Files

• 23 Jun: FDA greenlights generic rifapentine for tuberculosis. MedPage Today

• 23 Jun: US provides Ebola treatment for outbreak in Congo, bringing trials closer. Reuters

• 23 Jun: How Ghana Slashed Child Malaria Deaths by 86%. Health Policy Watch

• 23 Jun: Africa’s progress is real and now we must scale what works. CNBC Africa

• 23 Jun: Four innovations that are changing patients’ lives. MSF

• 24 Jun: The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions. MSF

• 24 Jun: BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccine. Nature

• 24 Jun: Gavi and OPEC Fund partner to strengthen regional and local vaccine manufacturing, health financing and security. Gavi

• 24 Jun: UNICEF, Gavi launch call to speed Bundibugyo Ebola vaccine access. Reuters

• 24 Jun: As Ebola Cases Breach 1000, Trial of Two Antiviral Treatments Due to Start Soon. Health Policy Watch

• 24 Jun: WHO announces 2 trials of experimental drugs in Ebola outbreak. CIDRAP

• 24 Jun: Guarantee Equitable Access to Bundibugyo Ebola Countermeasures and Publish a Transparent Roadmap. The Independent Panel

• 24 Jun: Clinical trial set to test two drugs for fast-growing Ebola outbreak. STAT

• 24 Jun: Antibiotic cocktail made by soil bacteria can kill superbugs. Nature

• 24 Jun: Inspiring, shaping and sustaining an African research & development agenda. Nature

• 24 Jun: Researchers seek better antibiotics for newborn sepsis amid rising drug resistance. Nature

• 24 Jun: Clinical trial priorities, adaptive strategies, and equitable partnerships for the Bundibugyo Ebola outbreak. The Lancet

• 25 Jun: A new malaria mosquito is causing outbreaks in African cites. Here’s where it came from. Gavi

• 25 Jun: Africa CDC triples amount needed to fight Ebola. CIDRAP

• 25 Jun: Europe and Africa set to align global health priorities at EDCTP Forum 2027. Science Business

• 25 Jun: Gates MRI and IQVIA Partner to Advance R&D in Low- And Middle-Income Countries. Gates MRI

• 26 May: Devex CheckUp: WHA — what happened, and what happens next?. Devex

• 26 May: Why infectious disease innovation still needs long-term investment. Devex

• 26 Jun: NIH Budget Cuts Threaten HIV Research. Think Global Health

• 26 May: Snakebite – Long Ignored, Recently Recognized as Neglected Disease. Health Policy Watch

• 26 May: No more needles? Six technologies that could transform how we get vaccinated. Gavi

• 26 May: Ebola outbreak in the DRC: four reasons it will be hard to contain. Gavi

• 27 May: Devex Newswire: Ebola outbreak outruns science as cases surge in DRC. Devex

• 27 May: The long, strange journey of mycetoma research. Global Health NOW

• 27 May: Can the near point-of-care TB test close the diagnostic gap in Africa?. The Lancet

• 27 May: Spanish top health official: New global health architecture must break with ‘inherited structures’. Geneva Solutions

• 27 May: ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification. Health Policy Watch

• 27 May: The DRC Ebola outbreak has exposed the consequences of global health underfunding. BMJ

• 27 May: Climate crisis is accelerating antibiotic resistance across world, study says. The Guardian

• 27 Jun: Kenya set to benefit as Gavi speeds up Ebola vaccine search. The Star

• 28 May: Experimental vaccine triggers broadly neutralizing HIV antibodies in macaques. News Medical

• 28 May: Mosquitoes can become attracted to insect repellant, study suggests. The Guardian

• 28 May: African Union's health agency vows Ebola Bundibugyo vaccine by end of 2026. MedicalXpress

• 28 May: Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus. WHO

• 28 May: Adapting the global research agenda to local contexts. WHO

• 28 May: WHO identifies Ebola treatments, vaccines to be tested in trials amid outbreak. Reuters

• 28 May: Outdoor mosquito control must be part of integrated mosquito management. Devex

• 29 Jun: From compost to clinic: the fungus that could let Africa design its own vaccines at a dollar a dose. Gavi

• 29 Jun: New schistosomiasis vaccine induces robust immune memory responses. News Medical

• 29 May: The scent of supper: Can mosquitoes learn to love DEET?. CIDRAP

• 29 May: New antibiotic design could help treat drug-resistant infections. MedicalXpress

• 29 May: Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial. The Lancet

• 29 May: A rifamycin-free regimen for shortened tuberculosis treatment. The Lancet

• 29 May: Can We Build a Future of Global Health That Works Better for Everyone?. Boston University

• 29 May: How ‘boom and bust’ Ebola R&D funding leaves us vulnerable. Impact Global Health

• 30 Jun: Why a surge in sexually transmitted infections in Europe should worry everybody. The Guardian

• 31 May: CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates. CEPi

Upcoming Meetings/  Webinars

--------------------------